Accueil・Liste d'Actions・Bio-Rad Laboratories Inc

Bio-Rad Laboratories Inc

Fermé

SecteurSoins de santé

352.01 3.13

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

346.08

Max

352.8

Chiffres clés
By Trading Economics
Revenu	-731M -11M
Ventes	-101M 592M
P/E Moyenne du Secteur	55.6 68.51
BPA	1.89
Marge bénéficiaire	-1.858
Employés	7,450
EBITDA	-751M -637M

Recommandations
By TipRanks
Recommandations	Neutre
Prévisions sur 12 Mois	-6.02% downside

Dividendes
By Acuity
Prochains Résultats	28 oct. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	1.2B 9B
Ouverture précédente	348.88
Clôture précédente	352.01

Sentiment de l'Actualité

By Acuity

50%

116 / 340 Classement par Healthcare

Bio-Rad Laboratories Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

7 août 2026, 23:56 UTC

Bio Rad Laboratories Inc. shares declined in after-market trading, reflecting routine fluctuations. The stock remains above its 20-day moving average.

6 août 2026, 20:07 UTC

Bio Rad Laboratories Inc shares are lower today, breaking a recent trend of gains. No specific news was identified to explain this decline.

5 août 2026, 20:03 UTC

News

Bio Rad Laboratories shares are higher as RBC raises its price target to $370. Wells Fargo and Citigroup also updated their price targets to $330.

4 août 2026, 22:02 UTC

News

Bio-Rad Laboratories shares are lower in after-market trading following a restructuring announcement and lowered full-year sales guidance despite strong second-quarter earnings.

3 août 2026, 19:46 UTC

Bio Rad Laboratories Inc is trading higher, supported by broader market trends amid falling oil prices. The stock remains near the upper end of its one-month range.

30 juil. 2026, 20:09 UTC

Bio Rad Laboratories shares are trading roughly flat amid mixed economic signals, including lower-than-expected U.S. GDP growth and rising initial jobless claims.

29 juil. 2026, 18:01 UTC

Bio Rad Laboratories Inc shares are lower today, continuing a decline since Tuesday's close. The broader market reacts to rising crude oil prices and inflation concerns.

28 juil. 2026, 17:03 UTC

Bio Rad Laboratories Inc. shares are higher today, diverging from a declining Nikkei 225 Index amid concerns over tech stock sustainability and rising semiconductor production in China.

27 juil. 2026, 19:46 UTC

Bio Rad Laboratories Inc shares are higher today, reaching a session high as crude oil prices decline. No specific company news was identified.

24 juil. 2026, 19:11 UTC

Bio Rad Laboratories Inc shares are lower, impacted by declines in the Life Sciences Tools & Services sub-sector. Earlier, they rebounded from a session low.

23 juil. 2026, 20:03 UTC

Correlated Moves

Bio Rad Laboratories Inc shares are higher, supported by gains in the Life Sciences Tools & Services sector and positive sentiment from Thermo Fisher Scientific Inc.

22 juil. 2026, 20:07 UTC

Bio Rad Laboratories Inc shares are higher today, maintaining a position above their 20-day moving average and near the upper end of their one-month range.

21 juil. 2026, 16:26 UTC

News

Bio-Rad Laboratories Inc shares are lower amid negative sentiment surrounding Sartorius, which reported disappointing earnings from Danaher’s bioprocessing unit.

20 juil. 2026, 19:17 UTC

Correlated Moves

BIO shares lower; iShares U.S. Healthcare ETF declines during session.

Comparaison

Variation de prix

Bio-Rad Laboratories Inc prévision

Objectif de Prix

By TipRanks

-6.02% baisse

Prévisions sur 12 Mois

Moyen 331.25 USD -6.02%

Haut 390 USD

Bas 275 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

4 ratings

Achat

Maintien

Vente

Basé sur 4 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Sentiment

By Acuity

116 / 340Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.